日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Gemogenovatucel-T Advantage in Clonal Tumor Mutation Burden-High Ovarian Cancer

Gemogenovatucel-T 在克隆性肿瘤突变负荷高卵巢癌中的优势

Coleman, Robert L; Rocconi, Rodney; Monk, Bradley J; Walter, Adam; Stanbery, Laura; Willoughby, David; Nagel, Casey; Wei, Qi; Wallraven, Gladice; Horvath, Staci; Tang, Min; Rao, Donald; Bognar, Ernest; Nemunaitis, John

Preclinical assessment of GNE(wt)/bi-shRNA-GNE(M743T) lipoplex product development for GNE myopathy

GNE(wt)/bi-shRNA-GNE(M743T)脂质体复合物产品开发治疗GNE肌病的临床前评估

Kerneis, Fabienne; Jay, Christopher M; Rao, Donald; Winchester, Jeremy; Nemunaitis, Alexander; Nemunaitis, Emily; Bognar, Ernest; Wallraven, Gladice; Stanbery, Laura; Walter, Adam; Sarshar, Sep; Nemunaitis, John

Exome sequencing shows same pattern of clonal tumor mutational burden, intratumor heterogenicity and clonal neoantigen between autologous tumor and Vigil product

外显子组测序显示,自体肿瘤和Vigil产品之间克隆性肿瘤突变负荷、肿瘤内异质性和克隆性新抗原的模式相同。

Willoughby, David; Bognar, Ernest; Stanbery, Laura; Nagel, Casey; Wallraven, Gladice; Pruthi, Aman; Bild, Nicholas; Stamper, Ericca; Rao, Donald; Walter, Adam; Nemunaitis, John

Clinical characterization and therapeutic targeting of fusion genes in oncology

肿瘤融合基因的临床特征及治疗靶向

Morand, Susan; Rager, Lauren; Craig, Daniel; Nemunaitis, Alexander; Choucair, Khalil; Rao, Donald; Stanbery, Laura; Phinney, Richard C; Walter, Adam; Ghisoli, Maurizio; Nemunaitis, John

Smart exosomes enhance PDAC targeted therapy.

智能外泌体增强胰腺癌靶向治疗

Creeden Justin F, Sevier Jonathan, Zhang Jian-Ting, Lapitsky Yakov, Brunicardi F Charles, Jin Ge, Nemunaitis John, Liu Jing-Yuan, Kalinoski Andrea, Rao Donald, Liu Shi-He

Gemogenovatucel-T (Vigil): bi-shRNA plasmid-based targeted immunotherapy

Gemogenovatucel-T(Vigil):基于双shRNA质粒的靶向免疫疗法

Nemunaitis, John; Stanbery, Laura; Walter, Adam; Wallraven, Gladice; Nemunaitis, Alexander; Horvath, Staci; Bognar, Ernest; Rao, Donald; Engle, Steven; Brun, Scott; Ghisoli, Maurizio; Rocconi, Rodney P; Monk, Bradley J; Coleman, Robert L

Three-year Follow up of GMCSF/bi-shRNA(furin) DNA-transfected Autologous Tumor Immunotherapy (Vigil) in Metastatic Advanced Ewing's Sarcoma

转移性晚期尤文氏肉瘤患者接受GM-CSF/bi-shRNA(furin) DNA转染自体肿瘤免疫疗法(Vigil)的三年随访

Ghisoli, Maurizio; Barve, Minal; Mennel, Robert; Lenarsky, Carl; Horvath, Staci; Wallraven, Gladice; Pappen, Beena O; Whiting, Sam; Rao, Donald; Senzer, Neil; Nemunaitis, John

PDX-1 is a therapeutic target for pancreatic cancer, insulinoma and islet neoplasia using a novel RNA interference platform

PDX-1 是一种利用新型 RNA 干扰平台治疗胰腺癌、胰岛素瘤和胰岛肿瘤的治疗靶点。

Liu, Shi-He; Rao, Donald D; Nemunaitis, John; Senzer, Neil; Zhou, Guisheng; Dawson, David; Gingras, Marie-Claude; Wang, Zhaohui; Gibbs, Richard; Norman, Michael; Templeton, Nancy S; Demayo, Francesco J; O'Malley, Bert; Sanchez, Robbi; Fisher, William E; Brunicardi, F Charles

Lung cancer chemoprevention with celecoxib in former smokers

塞来昔布对戒烟者进行肺癌化学预防

Jenny T Mao, Michael D Roth, Michael C Fishbein, Denise R Aberle, Zuo-Feng Zhang, Jian Yu Rao, Donald P Tashkin, Lee Goodglick, E Carmack Holmes, Robert B Cameron, Steven M Dubinett, Robert Elashoff, Eva Szabo, David Elashoff